Study guide

3.2 Storage, Transport & Expiration

Specialist in Blood Banking, SBB ASCP

Track your progress as you read

Finished sections get a check mark.

1 Introduction & Exam Overview

1.1 Current Exam Facts 1.2 Eligibility Routes & Credential Maintenance 1.3 Study Strategy for SBB

2 Donors & Collection

2.1 Donor Qualification 2.2 Collection Methods & Adverse Reactions 2.3 Special Donations

3 Processing, Storage & Component QC

3.1 Processing, Testing & Labeling 3.2 Storage, Transport & Expiration 3.3 Blood Component Quality Control

4 Red Cell & Modified Components

4.1 Whole Blood & Red Blood Cells 4.2 Leukocyte-Reduced, Washed, Frozen & Rejuvenated RBCs 4.3 Irradiated Components 4.4 Granulocytes

5 Platelets, Plasma & Cellular Products

5.1 Platelets 5.2 Plasma & Cryoprecipitated AHF 5.3 Apheresis Products & Fractionation Products 5.4 Hematopoietic Progenitors

6 Genetics, ABO & Rh

6.1 Blood Group Genetics & Molecular Inheritance 6.2 ABO & Lewis Systems 6.3 Rh System 6.4 MNS, P1PK/Globoside & Ii

7 Other Blood Groups & Role in Transfusion

7.1 Kell, Kidd, Duffy & Lutheran 7.2 Other Systems & High/Low-Prevalence Antigens 7.3 HLA, Platelet-Specific & Granulocyte Antigens 7.4 Immunogenicity & Antigen Prevalence

8 Immunology Foundations

8.1 Immune Response 8.2 Immunoglobulins 8.3 Antigen-Antibody Interactions 8.4 Complement

9 Physiology, Hemostasis & HDFN

9.1 Physiology of Blood 9.2 Hemostasis and Coagulation 9.3 HDFN Pathophysiology & Detection 9.4 HDFN Treatment & Prevention

10 Cytopenias & Transplantation

10.1 Immune & Nonimmune Anemia 10.2 Thrombocytopenia & Neutropenia 10.3 Solid Organ Transplantation Support 10.4 Hematopoietic Progenitor Cell Transplantation

11 Routine Serologic Testing

11.1 Blood Grouping Tests 11.2 Antibody Detection & Crossmatch 11.3 Antibody Identification & Clinical Significance 11.4 Direct Antiglobulin Testing & Reagents

12 Special Serologic Methods

12.1 Enzymes, Enhancement Media & Lectins 12.2 Adsorptions, Elutions & Titrations 12.3 Cell Separations, Neutralization & Thiol Reagents 12.4 Chloroquine Diphosphate & EDTA-Glycine Acid

13 Molecular Platforms & Serologic QA

13.1 Molecular Blood Group Techniques 13.2 ELISA, Immunofluorescence, Solid Phase & Column Agglutination 13.3 Serologic Quality Assurance

14 Indications, Component Therapy & PBM

14.1 Indications for Transfusion 14.2 Component Therapy 14.3 Blood Administration & Patient Blood Management

15 Adverse Effects of Transfusion

15.1 Immunologic Transfusion Reactions 15.2 Nonimmunologic Reactions 15.3 Transfusion-Transmitted Diseases

16 Apheresis & Extracorporeal Circulation

16.1 Therapeutic Apheresis 16.2 Extracorporeal Circulation

17 Quality, Safety, Math & Instrumentation

17.1 Quality Assessment & Troubleshooting 17.2 Laboratory Safety 17.3 Laboratory Mathematics 17.4 Instrumentation

18 Laboratory Administration (SBB Only)

18.1 Financial Management 18.2 Operations & Information Technology 18.3 Personnel, Education & Training 18.4 Quality Management, Risk & Tissue Management

3.2 Storage, Transport & Expiration

Key Takeaways Explain This Topic AI

Anticoagulant-preservative solutions (CPD, CPD2, CPDA-1) and additive solutions (AS-1, AS-3, AS-5, etc.) determine red cell shelf life — CPDA-1 whole blood/RBCs last 35 days, while additive-solution RBCs last 42 days

Red blood cells and whole blood are stored at 1–6°C; platelets at 20–24°C with continuous gentle agitation; fresh frozen plasma and cryoprecipitate are stored frozen at ≤-18°C (≤-65°C preferred for extended dating)

Platelets have the shortest routine shelf life (5 days, or up to 7 with approved bacterial detection/pathogen reduction) because room-temperature storage supports bacterial growth and platelets lose function over time

Transport temperature requirements mirror storage requirements — RBCs must stay 1–10°C in validated shipping containers during transport, platelets must stay near room temperature and never be refrigerated

Expiration is a hard cutoff, not a guideline — a unit transfused even minutes past its labeled expiration is out of compliance regardless of apparent product quality

Last updated: July 2026

Storage, Transport & Expiration

Quick Answer: Red blood cells are stored at 1–6°C for 21–42 days depending on the anticoagulant/additive solution used; platelets are stored at 20–24°C with continuous gentle agitation for 5–7 days; plasma and cryoprecipitate are stored frozen. Every component's exact shelf life is a direct function of its anticoagulant/preservative chemistry and storage temperature, and expiration is enforced as a hard cutoff. This section covers anticoagulant/additive chemistry, temperature and agitation requirements by component, transport validation, and expiration logic.

I.C — Anticoagulant-Preservative Solutions

Whole blood cannot be stored without an anticoagulant to prevent clotting and a preservative to sustain red cell metabolism. The standard solutions are all citrate-based (citrate chelates calcium to prevent coagulation) but differ in their additional components:

  • Solution Components (beyond citrate) Approved RBC Shelf Life
  • CPD (Citrate-Phosphate-Dextrose) Phosphate (buffer), dextrose (energy source) 21 days
  • CP2D (Citrate-Phosphate-2-Dextrose) Double dextrose concentration vs. CPD 21 days
  • CPDA-1 (Citrate-Phosphate-Dextrose-Adenine) Adenine added to extend ATP synthesis 35 days

Adenine is the key addition in CPDA-1: red cells use adenine as a substrate to resynthesize ATP throughout storage, which slows the decline in cell viability and extends shelf life from 21 to 35 days relative to CPD alone.

Additive Solutions

After whole blood is collected into CPD (or CP2D) and the plasma is removed, an additive solution can be added directly to the red cell concentrate to further extend storage and improve flow characteristics for transfusion. Common additive solutions (composition varies by manufacturer but generally includes saline, adenine, glucose/dextrose, and — for some formulations — mannitol as a red cell membrane stabilizer):

  • Additive Solution Distinguishing Feature RBC Shelf Life (with CPD/CP2D collection)
  • AS-1 (Adsol) Contains mannitol 42 days
  • AS-3 (Nutricel) Contains additional phosphate and citrate instead of mannitol 42 days
  • AS-5 (Optisol) Contains mannitol 42 days
  • AS-7 / AS-8 (newer formulations) Manufacturer-specific refinements 42 days

All major additive solutions extend RBC storage to 42 days , which is the current maximum routine dating for liquid-stored RBCs in the U.S. Additive solutions also reduce the hematocrit of the red cell unit and improve deformability/flow for transfusion, which is why additive-solution RBCs infuse more easily than CPDA-1 whole-blood-derived RBCs without additive.

Storage Conditions by Component

  • Component Storage Temperature Agitation Typical Shelf Life
  • Whole Blood / RBCs (CPD, CP2D) 1–6°C None 21 days
  • Whole Blood / RBCs (CPDA-1) 1–6°C None 35 days
  • RBCs with additive solution 1–6°C None 42 days

Frozen (glycerolized) RBCs ≤-65°C None Up to 10 years (deglycerolized units expire in 24 hours post-thaw, open system; shorter for closed-system variants per validation)

Platelets (room temperature) 20–24°C Continuous gentle agitation 5 days (up to 7 days with approved bacterial risk mitigation, e.g., culture-based detection or pathogen reduction)

Cold-stored platelets 1–6°C None Shorter dating; used in specific trauma/military contexts per applicable approvals

  • Fresh Frozen Plasma (FFP) ≤-18°C (≤-65°C for extended dating) None 1 year at ≤-18°C; up to 7 years at ≤-65°C
  • Cryoprecipitated AHF ≤-18°C None 1 year from original collection

Thawed plasma 1–6°C None 24 hours (FFP, once thawed for immediate use) or up to 5 days for "thawed plasma" once relabeled

Thawed cryoprecipitate 20–24°C (room temperature, once thawed) None 4–6 hours; pooled cryoprecipitate has a shorter window

Granulocytes 20–24°C No agitation (agitation can damage granulocytes) 24 hours

Platelet agitation is not optional — continuous gentle agitation maintains platelet metabolism, gas exchange, and prevents aggregation/clumping during storage; platelets that are inadvertently refrigerated or left unagitated for extended periods lose function and cannot simply be "re-agitated" back to acceptable quality. This is why the exam and real-world QC both emphasize agitator monitoring and validation as a critical control point.

Frozen components (FFP, cryoprecipitate, frozen RBCs) rely on maintaining sub-freezing temperature to halt metabolic and enzymatic degradation; a partial thaw-refreeze event compromises the product and typically requires discard, since refreezing does not restore lost factor activity or cellular integrity.

Transport Requirements

Transport temperature ranges are validated extensions of storage temperature, not identical to it, because short transport excursions are tolerated if the product temperature stays within an approved range on arrival:

Component Transport Temperature Validation Requirement

RBCs / Whole Blood 1–10°C during transport Validated shipping containers (insulated coolers with coolant packs) must be qualified to maintain this range for the expected transit duration

Platelets As close to 20–24°C as possible; never refrigerated Insulated containers without ice/coolant contact; agitation resumes immediately on arrival

Frozen components Frozen state maintained (dry ice or validated frozen shippers) Must not thaw in transit

Thawed plasma / cryoprecipitate in transit for immediate use 1–6°C (plasma) or room temperature (cryo, short window) Time-critical; often used same-day

Every shipping container and route combination used routinely should be temperature-validated (e.g., via data loggers during qualification runs) rather than assumed compliant, and receiving facilities should spot-check arriving unit temperatures as part of receipt inspection.

Expiration Logic

Expiration dating is calculated from the date (and sometimes time) of collection , using the approved shelf life for the specific anticoagulant/additive/processing combination:

  • A CPDA-1 whole blood unit collected on Day 0 expires at the end of Day 35 (i.e., 35 days of storage life)
  • An additive-solution RBC unit collected on Day 0 expires at the end of Day 42

Modifying a component (e.g., pooling, opening the closed system for washing/volume reduction, irradiation) can shorten the expiration — opening a closed system converts storage to an open-system time limit (often 24 hours at 1–6°C) regardless of the original unexpired dating, because sterility can no longer be assured beyond that window

Irradiation of RBCs (to prevent transfusion-associated graft-versus-host disease) shortens shelf life to 28 days from irradiation or the original expiration date, whichever is sooner , because irradiation damages the red cell membrane and increases potassium leakage over time

Expiration is treated as an absolute cutoff in blood banking — a unit is either in-date or it is not, with no allowance for "probably still fine." Transfusing an expired unit is a reportable quality event regardless of whether the unit shows visible signs of degradation, because the approved dating reflects validated data on sterility, cell viability, and biochemical stability, not a visual inspection standard.

Practical Test-Taking Focus

Memorize the temperature bands (RBC 1–6°C, platelet 20–24°C agitated, frozen ≤-18°C/≤-65°C) and the relative shelf-life ordering (CPD 21 < CPDA-1 35 < additive solution 42 days; platelets shortest at 5–7 days) rather than every manufacturer-specific additive solution name. Exam items often test the consequence of a storage deviation (unagitated platelets, a partial thaw, an opened closed system) more than a raw number recall.